Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28392238 | 0.82 | GAA (0.44) | TSHRGAAMGAMSIMGAM2 | |
| SCHEMBL20816259 | 0.80 | ALDH1A1 (0.36) | TSHRALDH1A1ATM | |
| SCHEMBL17222426 | 0.74 | ALDH1A1 (0.35) | TSHRALDH1A1 | |
| SCHEMBL20816251 | 0.74 | CYP3A4 (0.41) | TSHRGAAALDH1A1LMNAKMT2A | |
| SCHEMBL15231719 | 0.73 | L3MBTL1 (0.44) | TSHRGAAMGAMSIMGAM2 | |
| SCHEMBL28465729 | 0.73 | GAA (0.35) | TSHRGAAMGAMSIMGAM2 | |
| SCHEMBL15255688 | 0.73 | — | — | |
| SCHEMBL2595628 | 0.71 | GAA (0.44) | TSHRGAAMGAMSIMGAM2 | |
| SCHEMBL16179493 | 0.71 | KMT2A (0.44) | TSHRGAAALDH1A1LMNAKMT2A | |
| SCHEMBL19216698 | 0.70 | GAA (0.50) | TSHRGAAMGAMSIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1712551-B1 | 3-Methyl oxetanemethanol derivatives and their use in perfume compositions | INT FLAVORS & FRAGRANCES INC (US) | 2012-11-21 | — | — | EP | disclosed |
| US-20070265180-A1 | 3-Methyl Oxetanemethanol Derivatives and Their Use in Perfume Compositions | INTERNATION FLAVORS & FRAGRANCES INC. | 2007-11-15 | — | — | US | disclosed |
| US-7265231-B2 | 3-methyl oxetanemethanol derivatives and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2007-09-04 | — | — | US | disclosed |
| US-20060234882-A1 | 3-Methyl oxetanemethanol derivatives and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2006-10-19 | — | — | US | disclosed |
| EP-1712551-A1 | 3-Methyl oxetanemethanol derivatives and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) | 2006-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265180-A1 | 3-Methyl Oxetanemethanol Derivatives and Their Use in Perfume Compositions | PNMT, CYP51A1, MSMO1 | TSHR 4747/4885GAA 4831/4885MGAM 2508/4885 |
| US-20060234882-A1 | 3-Methyl oxetanemethanol derivatives and their use in perfume compositions | PNMT, CYP51A1, MSMO1 | TSHR 4747/4885GAA 4831/4885MGAM 2508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.